Literature DB >> 30903594

MiR-1179 inhibits the proliferation of gastric cancer cells by targeting HMGB1.

Yongsheng Li1, Ce Qin2.   

Abstract

Gastric cancer is one of the most common aggressive malignancies with high incidence and mortality. Increasing evidence has suggested that microRNAs (miRNAs) are involved in the initiation and development of gastric cancer. Here, we found that miR-1179 was significantly down-regulated in both gastric cancer tissues and cell lines. Decreased expression of miR-1179 was remarkably correlated with the increased tumor size, higher tumor stage and lymph node metastasis of gastric cancer patients. Overexpression of miR-1179 significantly inhibited the proliferation and invasion of gastric cancer cells. Further molecular experiments showed that miR-1179 bound the 3'-untranslated region of the high mobility group box 1 (HMGB1) and decreased the expression of HMGB1 in gastric cancer cells. The level of HMGB1 was negatively correlated with the expression of miR-1179 in gastric cancer tissues. Rescue experiment demonstrated that restore the expression of HMGB1 significantly inversed the inhibitory effect of miR-1179 on the proliferation of gastric cancer cells. Our results uncovered the novel function of miR-1179/HMGB1 axis in the progression of gastric cancer.

Entities:  

Keywords:  Gastric cancer; HMGB1; MiR-1179

Mesh:

Substances:

Year:  2019        PMID: 30903594     DOI: 10.1007/s13577-019-00244-6

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  31 in total

Review 1.  The microRNA pathway and cancer.

Authors:  Pieter Bas Kwak; Shintaro Iwasaki; Yukihide Tomari
Journal:  Cancer Sci       Date:  2010-11       Impact factor: 6.716

Review 2.  Regulation of mRNA translation and stability by microRNAs.

Authors:  Marc Robert Fabian; Nahum Sonenberg; Witold Filipowicz
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

Review 3.  High-mobility group box 1 protein (HMGB1) gene polymorphisms and cancer susceptibility: A comprehensive meta-analysis.

Authors:  Taruna Kumari; Bhupender Kumar
Journal:  Clin Chim Acta       Date:  2018-05-03       Impact factor: 3.786

Review 4.  Circulating miRNAs: promising biomarkers of human cancer.

Authors:  Hongguang Qu; Weiwei Xu; Yuchuan Huang; Shujuan Yang
Journal:  Asian Pac J Cancer Prev       Date:  2011

Review 5.  Overview of microRNA biology.

Authors:  Ashley M Mohr; Justin L Mott
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

6.  MicroRNA-1179 inhibits glioblastoma cell proliferation and cell cycle progression via directly targeting E2F transcription factor 5.

Authors:  Xiupeng Xu; Ning Cai; Tongle Zhi; Zhongyuan Bao; Dong Wang; Yinlong Liu; Kuan Jiang; Liang Fan; Jing Ji; Ning Liu
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

Review 7.  miRNAs in human cancer.

Authors:  Thalia A Farazi; Jessica I Spitzer; Pavel Morozov; Thomas Tuschl
Journal:  J Pathol       Date:  2010-11-18       Impact factor: 7.996

8.  MicroRNA-1179 inhibits the proliferation, migration and invasion of human pancreatic cancer cells by targeting E2F5.

Authors:  Chengjie Lin; Zhigao Hu; Guandou Yuan; Huizhao Su; Yonglian Zeng; Zhenya Guo; Fudi Zhong; Keqing Jiang; Songqing He
Journal:  Chem Biol Interact       Date:  2018-05-31       Impact factor: 5.192

9.  Urine miR-21-5p as a potential non-invasive biomarker for gastric cancer.

Authors:  Hsiao-Wei Kao; Chao-Yu Pan; Chun-Hung Lai; Chew-Wun Wu; Wen-Liang Fang; Kuo-Hung Huang; Wen-Chang Lin
Journal:  Oncotarget       Date:  2017-04-07

10.  miRNA-543 promotes cell migration and invasion by targeting SPOP in gastric cancer.

Authors:  Junfei Xu; Feiran Wang; Xi Wang; Zhixian He; Xinguo Zhu
Journal:  Onco Targets Ther       Date:  2018-08-21       Impact factor: 4.147

View more
  15 in total

Review 1.  Molecular targeted treatment and drug delivery system for gastric cancer.

Authors:  Lanxin Jiang; Xiaomin Gong; Wangdi Liao; Nonghua Lv; Runwei Yan
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-07       Impact factor: 4.553

2.  miR-665 is downregulated in glioma and inhibits tumor cell proliferation, migration and invasion by targeting high mobility group box 1.

Authors:  Hao Shen; Ling Xu; Chunyue You; Huaibo Tang; Haitao Wu; Yong Zhang; Mingxiang Xie
Journal:  Oncol Lett       Date:  2020-12-31       Impact factor: 2.967

3.  MiR-1179 represses cell proliferation, migration and invasion of hepatocellular carcinoma through suppression of NUAK2.

Authors:  Dejun Wang; Xue Song; Nan Zhang; Yesong Guo
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

4.  CircUBR5 acts as a ceRNA for miR-1179 to up-regulate UBR5 and to promote malignancy of triple-negative breast cancer.

Authors:  Guohua Gong; Jikai She; Danni Fu; Dong Zhen; Bin Zhang
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

5.  miR-153-3p Attenuates the Development of Gastric Cancer by Suppressing SphK2.

Authors:  Zhengwo Jia; Xiaofang Tang; Xicheng Zhang; Jingen Shen; Yuanlong Sun; Lifen Qian
Journal:  Biochem Genet       Date:  2022-01-28       Impact factor: 2.220

6.  circ_0084927 promotes cervical carcinogenesis by sponging miR-1179 that suppresses CDK2, a cell cycle-related gene.

Authors:  Xinhua Qu; Liumei Zhu; Linlin Song; Shaohua Liu
Journal:  Cancer Cell Int       Date:  2020-07-21       Impact factor: 5.722

7.  Circ_0032821 Facilitates Gastric Cancer Cell Proliferation, Migration, Invasion and Glycolysis by Regulating MiR-1236-3p/HMGB1 Axis.

Authors:  Lei Chen; Kun Chi; Huaguo Xiang; Yan Yang
Journal:  Cancer Manag Res       Date:  2020-10-12       Impact factor: 3.989

8.  FOXA1-induced circOSBPL10 potentiates cervical cancer cell proliferation and migration through miR-1179/UBE2Q1 axis.

Authors:  Shanshan Yang; Yiwen Jiang; Xiaoli Ren; Dan Feng; Liaoyun Zhang; Deying He; Shiyao Hong; Li Jin; Fang Zhang; Shun Lu
Journal:  Cancer Cell Int       Date:  2020-08-12       Impact factor: 5.722

9.  Long Noncoding RNA LINC00525 Promotes the Aggressive Phenotype of Chordoma Through Acting as a microRNA-505-3p Sponge and Consequently Raising HMGB1 Expression.

Authors:  Lei Li; Guohua Lv; Bing Wang; Hong Ma
Journal:  Onco Targets Ther       Date:  2020-09-10       Impact factor: 4.345

Review 10.  HMGB1 as a therapeutic target in disease.

Authors:  Jiaming Xue; Joelle S Suarez; Michael Minaai; Shuangjing Li; Giovanni Gaudino; Harvey I Pass; Michele Carbone; Haining Yang
Journal:  J Cell Physiol       Date:  2020-10-26       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.